Integrated Procedural System Advances Approach to Minimally Invasive Surgery
Platform designed to significantly reduce radiation exposure helps make the OR safer for staff and patients
NuVasive Expands Applications of Porous PEEK Surface Technology to Lateral Surgery with First-of-its-Kind Cohere® XLIF Implant
Company sponsors Spine Summit 2019 - 35th Annual Meeting of the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves
SAN DIEGO, March 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management...
SAN DIEGO, Feb. 21, 2019 /PRNewswire/ -- NuVasive, Inc.
Company provides 2019 financial performance guidance
Company receives FDA 510(k) clearance and CE mark approval for use of minimally invasive Precice® Bone Transport System to treat segmental bone defects up to 10 centimeters in the tibia and femur
Shares surge after a report says London-based Smith & Nephew is considering buying the company.
The Dow Jones Industrial Average falls as investors eye progress in this week's renewed U.S.-China trade talks.
U.S. stock futures are higher as U.S.-China trade talks resume; Republican and Democratic lawmakers are working to broker an agreement that will prevent another government shutdown on Friday; Smith & Nephew reportedly has held talks to buy NuVasive; Activision could announce job cuts when it reports earnings Tuesday.
SAN DIEGO, Jan. 29, 2019 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Jan. 7, 2019 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Jan. 3, 2019 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Dec. 27, 2018 /PRNewswire/ -- NuVasive, Inc.
Company receives FDA 510(k) clearance for expanded use of Monolith® Corpectomy System, introducing fully modular PEEK implant indicated for use in the cervical spine
SAN DIEGO, Nov. 19, 2018 /PRNewswire/ -- NuVasive, Inc.
SAN DIEGO, Nov. 15, 2018 /PRNewswire/ -- NuVasive, Inc.
BH, ENLK, R, DVN and NUVA were all recently downgraded by TheStreet’s Quant Ratings service.
Company receives FDA 510(k) clearance for use of COHERE® interbody in XLIF® procedure as new clinical study further validates important benefits of Porous PEEK™ material technology
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BXMT, CHK, CHMI, CWEN, CWEN.A, EBMT, EFC, HASI, HIIQ, HMST, HTBI, HY, HZNP, JTPY, KNDI, LARK, LMRK, MBI, MFNC, MFSF, PBFX, RC, TEUM, UBNK, URG Downgrades: APTV, CFBK, CNFR, CPLP, CVEO, HF, HNGR, HPJ, IAG, INS, LGL, MAA, MCRN, MDRX, MHH, MTLS, NFBK, NUVA, OFED, OMI, VTSI, WNC, WSTL Initiations: I, ONS Read on to get TheStreet Quant Ratings' detailed report:
SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- NuVasive, Inc.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHEF, CLH, DYSL, FLR, FORM, GPOR, HI, IBM, KBR, KW, NUVA, TGE, WSTL, X Downgrades: EMKR, PSMT, SEB Initiations: APPN, APRN, GDI Read on to get TheStreet Quant Ratings' detailed report:
Investors in Nuvasive Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NUVA options chain for the new May 18th contracts and identified one put and one call contract of particular interest.
The most recent short interest data was recently released for the 11/30/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 10.32 "days to cover" versus the median component at 5.11. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.
Finding bullish and bearish reversals in the market.
Among them are a motorcycle maker and a seller of undergarments.
VIRT, HOG, HBI, NUVA and ATHN all recently were downgraded by TheStreet's Quant Ratings.
